[go: up one dir, main page]

LT4010379T - Faktoriaus xa ir jo darinių kompozicijos ir gamybos būdai - Google Patents

Faktoriaus xa ir jo darinių kompozicijos ir gamybos būdai

Info

Publication number
LT4010379T
LT4010379T LTEPPCT/US2020/045039T LTUS2020045039T LT4010379T LT 4010379 T LT4010379 T LT 4010379T LT US2020045039 T LTUS2020045039 T LT US2020045039T LT 4010379 T LT4010379 T LT 4010379T
Authority
LT
Lithuania
Prior art keywords
derivatives
compositions
methods
preparing factor
preparing
Prior art date
Application number
LTEPPCT/US2020/045039T
Other languages
English (en)
Inventor
Genmin Lu
Original Assignee
Alexion Pharmaceuticals, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alexion Pharmaceuticals, Inc. filed Critical Alexion Pharmaceuticals, Inc.
Publication of LT4010379T publication Critical patent/LT4010379T/lt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424Serine endopeptidases (3.4.21)
    • C12N9/6432Coagulation factor Xa (3.4.21.6)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/31Fusion polypeptide fusions, other than Fc, for prolonged plasma life, e.g. albumin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/50Fusion polypeptide containing protease site

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
LTEPPCT/US2020/045039T 2019-08-08 2020-08-05 Faktoriaus xa ir jo darinių kompozicijos ir gamybos būdai LT4010379T (lt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962884652P 2019-08-08 2019-08-08
US202062990885P 2020-03-17 2020-03-17
PCT/US2020/045039 WO2021026254A2 (en) 2019-08-08 2020-08-05 Compositions and methods for preparing factor xa and derivatives

Publications (1)

Publication Number Publication Date
LT4010379T true LT4010379T (lt) 2025-07-10

Family

ID=74502595

Family Applications (1)

Application Number Title Priority Date Filing Date
LTEPPCT/US2020/045039T LT4010379T (lt) 2019-08-08 2020-08-05 Faktoriaus xa ir jo darinių kompozicijos ir gamybos būdai

Country Status (13)

Country Link
US (1) US12398387B2 (lt)
EP (2) EP4010379B1 (lt)
JP (2) JP7668783B2 (lt)
CN (1) CN114258405A (lt)
DK (1) DK4010379T3 (lt)
ES (1) ES3033092T3 (lt)
FI (1) FI4010379T3 (lt)
HU (1) HUE072201T2 (lt)
LT (1) LT4010379T (lt)
PL (1) PL4010379T3 (lt)
PT (1) PT4010379T (lt)
SI (1) SI4010379T1 (lt)
WO (1) WO2021026254A2 (lt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20250171515A1 (en) * 2022-03-03 2025-05-29 The Trustees Of The University Of Pennsylvania Aav vectors for delivery of glp-1 receptor agonist fusions

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4818700A (en) 1985-10-25 1989-04-04 Phillips Petroleum Company Pichia pastoris argininosuccinate lyase gene and uses thereof
US4812405A (en) 1986-02-18 1989-03-14 Phillips Petroleum Company Double auxotrophic mutants of Pichia pastoris and methods for preparation
US4929555A (en) 1987-10-19 1990-05-29 Phillips Petroleum Company Pichia transformation
US5955349A (en) 1996-08-26 1999-09-21 Zymogenetics, Inc. Compositions and methods for producing heterologous polypeptides in Pichia methanolica
US5736383A (en) 1996-08-26 1998-04-07 Zymogenetics, Inc. Preparation of Pichia methanolica auxotrophic mutants
US6258559B1 (en) 1999-03-22 2001-07-10 Zymogenetics, Inc. Method for producing proteins in transformed Pichia
EP1728798A1 (en) 2005-06-01 2006-12-06 ZLB Behring GmbH Coagulation factor X polypeptides with modified activation properties
US7939632B2 (en) * 2006-06-14 2011-05-10 Csl Behring Gmbh Proteolytically cleavable fusion proteins with high molar specific activity
PL3078743T3 (pl) 2007-09-28 2020-11-02 Portola Pharmaceuticals, Inc. Antidotum dla inhibitorów czynnika XA i sposoby ich stosowania
ES2607935T3 (es) 2009-03-30 2017-04-04 Portola Pharmaceuticals, Inc. Antídotos para inhibidores del factor Xa y procedimientos de uso de los mismos
US20130230901A1 (en) * 2012-02-14 2013-09-05 Portola Pharmaceuticals, Inc. Process for making recombinant antidote to factor xa inhibitor
AU2013270682A1 (en) 2012-06-08 2014-12-11 Biogen Ma Inc. Procoagulant compounds
EP2861614B1 (en) * 2012-06-14 2016-11-30 Portola Pharmaceuticals, Inc. METHOD FOR PURIFICATION OF RECOMBINANT FACTOR Xa DERIVATIVES
US10364288B2 (en) * 2013-05-24 2019-07-30 Biogen Ma Inc. Anti-GPIIB/IIIA antibodies or uses thereof
CN103408669B (zh) * 2013-08-01 2016-01-20 江苏泰康生物医药有限公司 Glp-1类似物融合蛋白,及其制备方法和用途
WO2017147522A1 (en) 2016-02-24 2017-08-31 Portola Pharmaceuticals, Inc. Lyophilized formulations for factor xa antidote
FR3077296A1 (fr) * 2018-02-01 2019-08-02 Laboratoire Francais Du Fractionnement Et Des Biotechnologies Dimeres de variants du facteur x

Also Published As

Publication number Publication date
WO2021026254A2 (en) 2021-02-11
PT4010379T (pt) 2025-06-30
ES3033092T3 (en) 2025-07-30
CN114258405A (zh) 2022-03-29
EP4010379A4 (en) 2023-12-20
JP7668783B2 (ja) 2025-04-25
DK4010379T3 (da) 2025-06-30
SI4010379T1 (sl) 2025-08-29
US20220251534A1 (en) 2022-08-11
HUE072201T2 (hu) 2025-10-28
JP2022543302A (ja) 2022-10-11
WO2021026254A3 (en) 2021-03-18
EP4541887A3 (en) 2025-08-13
EP4010379A2 (en) 2022-06-15
US12398387B2 (en) 2025-08-26
FI4010379T3 (fi) 2025-06-26
EP4010379B1 (en) 2025-04-02
EP4541887A2 (en) 2025-04-23
PL4010379T3 (pl) 2025-07-28
JP2024180602A (ja) 2024-12-26

Similar Documents

Publication Publication Date Title
SG11202110922QA (en) Camptothecin derivatives
IL277079A (en) Cartirin preparations and methods of use
IL285302A (en) Compounds, preparations and methods
ZA202204675B (en) New methylquinazolinone derivatives
HUE066348T2 (hu) Heterociklusos flavon-származékok és az ezekhez kapcsolódó készítmények és eljárások
SG11202110879PA (en) Compositions and methods for preparing t cell compositions and uses thereof
EP3635119A4 (en) COMPOSITIONS AND PROCEDURES FOR GENO EDITING
HUE070924T2 (hu) 2-Hidroxicikloalkán-1-karbamoil-származékok
PL4077334T3 (pl) Pochodne furoindazolu
IL290815A (en) History of alpha-d-galactopyranoside
GB201917917D0 (en) Tobacco composition
IL286587A (en) Preparations of d-methyrosine and methods for their preparation
IL290325A (en) Biopharmaceutical preparations and related methods
IL287120A (en) Compounds, preparations and methods
GB201904744D0 (en) Anti-fungal compositions
PL4010379T3 (pl) Kompozycje i sposoby wytwarzania czynnika xa i pochodnych
SG11202108262VA (en) Bacterialcidal methods and compositions
GB201919210D0 (en) Dihydro-cyclopenta-isoquinoline derivatives
GB201916122D0 (en) New compositions
IL286774A (en) Investment powder
ZA202200181B (en) 2-hydroxycycloalkane-1-carbamoyl derivatives
GB201904495D0 (en) Investment powder
GB201917066D0 (en) Methods and compositions
HK40060597A (zh) 熔模粉末
GB201916829D0 (en) Methods for preparing cannabinoid compositions